Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing

Vera A Paulson1,2, Ivan A Stojanov3, Jay K Wasman4

  • 1Department of Pathology, Boston Children's Hospital, Boston, MA, USA.

Insights

Cranial fasciitis, a pediatric scalp lesion, is now understood to frequently involve USP6 rearrangements, similar to nodular fasciitis. Targeted RNA sequencing successfully identified these genetic alterations, aiding diagnosis.

Area of Science:

  • Oncology
  • Genetics
  • Pediatric Pathology

Background:

  • Cranial fasciitis is a benign myofibroproliferative lesion of the pediatric scalp.
  • It shares histological similarities with nodular fasciitis, a neoplastic process characterized by USP6 translocations.
  • The molecular basis of cranial fasciitis remains less understood compared to nodular fasciitis.

Purpose of the Study:

  • To investigate the presence and spectrum of USP6 rearrangements in cranial fasciitis.
  • To determine if cranial fasciitis shares the USP6 fusion profile seen in nodular fasciitis.
  • To evaluate the utility of targeted RNA sequencing in identifying USP6 fusions in cranial fasciitis.

Main Methods:

  • Archival samples from fifteen cranial fasciitis cases were analyzed.
  • A targeted RNA sequencing panel was employed to detect gene rearrangements, including USP6.
  • USP6 rearrangements were identified and characterized, including novel fusion partners.

Main Results:

  • USP6 rearrangements were detected in five out of fifteen (33%) cranial fasciitis cases.
  • Three novel USP6 fusions were identified: SERPINH1-USP6 (two cases) and COL3A1-USP6 (one case).
  • Other identified USP6 fusions included SPARC-USP6 and MYH9-USP6.

Conclusions:

  • USP6 rearrangements are recurrent in cranial fasciitis, supporting its classification as a neoplastic process.
  • The findings reinforce the biological relationship between cranial fasciitis and nodular fasciitis.
  • Targeted RNA sequencing is an effective tool for diagnosing cranial fasciitis by identifying USP6 alterations.